EXPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID7272813560

KRS0000675635

Share capital100,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. ELEKTRONOWA 6, 94-103 ŁÓDŹ

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

EXPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. ELEKTRONOWA 6, 94-103 ŁÓDŹ

Show on map

NIP

7272813560

REGON

367153877

KRS

0000675635

Legal form

limited liability company

Register Address

UL. ELEKTRONOWA 6, 94-103 ŁÓDŹ

Date of registration in KRS

2017-04-27

Date of commencement of economic activity

2017-04-27

Act signature

LD.XX NS-REJ.KRS/28687/22/571

Pkd codes

46.46.Z - Wholesale of pharmaceutical goods

45.1 - Sale of motor vehicles

46.1 - Wholesale on a fee or contract basis

46.45.Z - Wholesale of perfume and cosmetics

46.75.Z - Wholesale of chemical products

63.12.Z - Web portals

73.1 - Advertising

86.90.A - Physiotherapeutical activities

86.90.D - Paramedical activities

86.90.E - Other human health activities notelsewhere classified

Payer VAT status

Unregirestered

Company authorities

representation authorityMANAGEMENT

representation type

KAŻDY CZŁONEK ZARZĄDU MA PRAWO REPREZENTOWANIA SPÓŁKI SAMODZIELNIE.

MANAGEMENT

Przemysław Chudek

Member Of The Board, 46 years old

shareholders

Tomasz Marek Matelski

100% 2000 udziałów o łącznej wartości 100.000,00 złotych

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2018	2019
	M PLN	M PLN	%
Profit (loss) on sale	0,3	0,2	-38,6
Gross profit (loss)	0,3	0,1	-55,5
EBITDA	0,3	0,2	-51,5
Short time liabilities	0,2	0,2	19,7
Other operating costs	0	0,1	267,1
Equity capital	0,6	0,8	16,9
Operating profit (EBIT)	0,3	0,1	-58,4
Assets	1,5	1,4	-9,2
Net profit (loss)	0,3	0,1	-56,8
Cash	0,7	0	-93,3
Net income from sale	6,9	6,9	-0,1
Liabilities and provisions for liabilities	0,9	0,6	-28,5
Working assets	1,5	1,3	-9,2
Other income costs	0	0	134,1
Depreciation	0	0	56,4
	%	%	p.p.
Profitability of capital	39,1	14,4	-24,7
Equity capital to total assets	42,5	54,7	12,2
Gross profit margin	4,5	2	-2,5
EBITDA Margin	5	2,4	-2,6
	Days	Days	Days
Short term commitment turnover cycle	9	11	2

Current financial liquidity indicator	8.852355003356934	6.7125244140625	-2,2
Net dept to EBITDA	-0.9346832036972046	1.8862032890319824	2,8